2021
DOI: 10.3390/v13071227
|View full text |Cite
|
Sign up to set email alerts
|

A Hepatitis B Virus-Derived Peptide Can Inhibit Infection of Human Lung Cells with SARS-CoV-2 in a Type-1 Interferon-Dependent Manner

Abstract: The current COVID-19 pandemic has highlighted the urgent need to develop effective therapeutic strategies. We evaluated the in vitro antiviral effect against SARS-CoV-2 of a hepatitis B virus (HBV) hexamer peptide, Poly6, which is capable of eliciting an antiviral effect against human immunodeficiency virus -1 (HIV-1), as a novel HIV-1 integrase inhibitor, and a strong anticancer immune response in an IFN-I-dependent manner, as a novel potential adjuvant in anticancer immunotherapy. Here, we report that Poly6 … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 45 publications
(49 reference statements)
0
1
0
Order By: Relevance
“…Peptide repositioning has been converted into a shorter pathway to explore other benefits and find new applications [25,68,69]. Some peptides have been tested in vitro against SARS-CoV-2 [70][71][72]. Brilacidin acts at the viral entry, thus altering the integrity of the virus.…”
Section: Discussionmentioning
confidence: 99%
“…Peptide repositioning has been converted into a shorter pathway to explore other benefits and find new applications [25,68,69]. Some peptides have been tested in vitro against SARS-CoV-2 [70][71][72]. Brilacidin acts at the viral entry, thus altering the integrity of the virus.…”
Section: Discussionmentioning
confidence: 99%